Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome

Diabetes, Obesity and Metabolism

Volumn 6, Issue 3, 2004, Pages 208-215

  Niskanen, Leo ^a   Laaksonen, D E ^a   Punnonen, K ^a   Mustajoki, P ^b   Kaukua, J ^a   Rissanen, A ^c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b PEIJAS HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Metabolic syndrome; Sex hormones; Weight loss

Indexed keywords

ESTRADIOL; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; TESTOSTERONE BLOOD LEVEL; WEIGHT REDUCTION;

EID: 2342437121     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1462-8902.2004.00335.x     Document Type: Article

References (36)

1. Anawalt BD, Merriam GR. Neuroendocrine aging in men. Andropause and somatopause. Endocrinol Metab Clin North Am 2001; 30: 647-669.
2. Wespes E, Schulman CC. Male andropause: myth, reality, treatment. Int J Impot Res 2002; 14 (Suppl. 1): S93-S98.
3. Morales A, Tenover JL. Androgen deficiency in the aging male: when, who, and how to investigate and treat. Urol Clin North Am 2002; 29: 975-982.
4. Vermeulen A. Andropause. Maturitas 2000; 34: 5-15.
5. Seidell JC, Visscher TL. Body weight and weight change and their health implications for the elderly. Eur J Clin Nutr 2000; 54 (Suppl. 3): S33-S39.
6. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996; 143: 889-897.
7. Haffner SM. Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance. epidemiological and clinical correlation. Int J Obes Relat Metab Disord 2000; 24 (Suppl. 2): S56-S58.
8. Abate N, Haffner SM, Garg A, Peshock RM, Grundy SM. Sex steroid hormones, upper body obesity, and insulin resistance. J Clin Endocrinol Metab 2002; 87: 4522-4527.
9. Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci 2002; 102: 151-166.
10. Tuomilehto J, Lindstrom J, Eriksson JG et al. for the Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
11. Laaksonen DE, Laitinen T, Schonberg J, Rissanen A, Niskanen LK. Weight loss and weight maintenance, ambulatory blood pressure and cardiac autonomic tone in obese persons with the metabolic syndrome. J Hypertens 2003; 21: 371-378.
12. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
13. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 2402-2410.
14. Anderson DC, Thorne MO, Fisher RA, Woodham JP, Goble HL, Besser CM. Effects of hormonal treatment on plasma unbound androgen levels in hirsute women. Acta Endocrinol (Copenh) 1975; 80 (Suppl. 199): 224.
15. Wheeler MJ. The determination of bio-available testosterone. Ann Clin Biochem 1995; 32: 345-357.
16. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-3672.
17. Mårin P, Holmäng S, Jönsson L et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord 1992; 12: 991-997.
18. Strain W, Zumoff B, Miller L et al. Effect of massive weight loss on hypothalamus-pituitary-gonadal function in obese men. J Clin Endocrinol Metab 1988; 66: 1019-1023.
19. Stanik S, Dornfeld LP, Maxwell MH, Viosca SP, Korenman SG. The effect of weight loss on reproductive hormones in obese men. J Clin Endocrinol Metab 1981; 53: 828-832.
20. Klibanski A, Beitins IZ, Badger T, Little R, McArthur JW. Reproductive function during fasting in men. J Clin Endocrinol Metab 1981; 53: 258-263.
21. Hoffer LJ, Beitins IZ, Kyung NH, Bistrian BR. Effects of severe dietary restriction on male reproductive hormones. J Clin Endocrinol Metab 1986; 62: 288-292.
22. Leenen R, van der Kooy K, Seidell JC, Deurenberg P, Koppeschaar HP. Visceral fat accumulation in relation to sex hormones in obese men and women undergoing weight loss therapy. J Clin Endocrinol Metab 1994; 78: 1511-1520.
23. Seidell JC, Björntorp P, Sjöström L, Kvist H, Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990; 39: 897-901.
24. Kraemer WJ, Volek JS, Clark KL et al. Influence of exercise training on physiological and performance changes with weight loss in men. Med Sci Sports Exerc 1999; 31: 1320-1329.
25. Kaukua J, Pekkarinen T, Sane T, Mustajoki P. Sex hormones and sexual function in obese men losing weight. Obes Res 2003; 11: 689-694.
26. Vierhapper H, Nowotny P, Waldhausl W. Reduced production rates of testosterone and dihydrotestosterone in healthy men treated with rosiglitazone. Metabolism 2003; 52: 230-232.
27. Furnsinn C, Nowotny P, Brunmair B et al. Thiazolidinediones influence plasma steroids of male obese Zucker rats. Endocrinology 2002; 143: 327.
28. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001; 86: 1418-1421.
29. Walker BR. Steroid metabolism in metabolic syndrome X. Best Pract Res Clin Endocrinol Metab 2001; 15: 111-122.
30. Bruning JC, Gautam D, Burks DJ et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000; 22: 2066-2067.
31. Masuzaki H, Paterson J, Shinyama H et al. Transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2071-2072.
32. Davani B, Khan A, Hult M et al. Type 1 11beta-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets. J Biol Chem 2000; 275: 34841-34844.
33. Dötsch J, Rascher W. Role of 11b-hydroxysteroid dehydrogenase activity in the metabolic syndrome: Lessons learned from the animal model. Eur J Endocrinol 2002; 146: 603-605.
34. Meinhardt U, Mullis PE. The aromatase cytochrome P-450 and its clinical impact. Horm Res 2002; 57: 145-152.
35. Wickman S, Saukkonen T, Dunkel L. The role of sex steroids in the regulation of insulin sensitivity and serum lipid concentrations during male puberty: a prospective study with a P450-aromatase inhibitor. Eur J Endocrinol 2002; 146: 339-346.
36. Murata Y, Robertson KM, Jones ME, Simpson ER. Effect of estrogen deficiency in the male: the ArKO mouse model. Mol Cell Endocrinol 2002; 193: 7-12.